Clinical trial
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in…
NCT00360490 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00360490 |
|---|---|
| Title | Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS) |
| Official title | A Multicenter, Randomized, Open Label, Parallel Group, Active Control Study to Evaluate the Efficacy and Safety of LNG IUS (Mirena®) as Compared to Medroxyprogesterone Acetate During 6 Cycles of Treatment in Patients With Idiopathic Menorrhagia |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menorrhagia |
| Intervention type | Drug |
| Interventions | Levonorgestrel IUS (Mirena, BAY86-5028), Medroxyprogesterone acetate |
| Enrollment | 165 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Dec 9, 2013 |
| Countries | Argentina, Brazil, Canada, Mexico, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: